Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Genes|August 26, 2022
Relationship between Nutrition, Lifestyle, and Neurodegenerative Disease: Lessons from <i>ADH1B</i>, <i>CYP1A2</i> and <i>MTHFR</i>Shila Barati, Carlo Fabrizio, Claudia Strafella, et al.
Progress in Retinal and Eye Research|December 4, 2017
Towards the application of precision medicine in Age-Related Macular DegenerationRaffaella Cascella, Claudia Strafella, Valerio Caputo, et al.
Biomedicines|July 29, 2025
Expanding Genetic and Clinical Spectra of Inherited Retinal Dystrophies: Identification of Three Novel <i>PRPH2</i> VariantsRaffaella Cascella, Jacopo Sebastiani, Claudia Strafella, et al.
Journal of Personalized Medicine|July 27, 2022
WARE: Wet AMD Risk-Evaluation Tool as a Clinical Decision-Support System Integrating Genetic and Non-Genetic FactorsCarlo Fabrizio, Andrea Termine, Valerio Caputo, et al.
Frontiers in Genetics|September 7, 2023
Whole exome sequencing highlights rare variants in <i>CTCF</i>, <i>DNMT1</i>, <i>DNMT3A</i>, <i>EZH2</i> and <i>SUV39H1</i> as associated with FSHDClaudia Strafella, Valerio Caputo, Sara Bortolani, et al.
Journal of Personalized Medicine|September 28, 2021
Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric DisordersStefania Zampatti, Carlo Fabrizio, Michele Ragazzo, et al.
Genes|October 17, 2019
NGS Analysis for Molecular Diagnosis of Retinitis Pigmentosa (RP): Detection of a Novel Variant in <i>PRPH2</i> GeneClaudia Strafella, Valerio Caputo, Giulia Pagliaroli, et al.
Neurogenetics|March 27, 2019
Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS eraStefania Zampatti, Luca Colantoni, Claudia Strafella, et al.
Clinical Genetics|August 11, 2025
The Role of Whole-Exome Sequencing and Methylation Analysis in Untangling Complex Facioscapulo-Humeral Muscular Dystrophy CasesFrancesca Torri, Claudia Strafella, Liliana Vercelli, et al.
Oncotarget|December 10, 2017
<i>KIF3A</i> and <i>IL-4</i> are disease-specific biomarkers for psoriatic arthritis susceptibilityRaffaella Cascella, Claudia Strafella, Michele Ragazzo, et al.
Pageof 6